Hip and knee prostheses are used millions of times. But due to the Iran war, more and more operations are being postponed.
Zimmer Biomet lays off employees, healthcare giant Johnson & Johnson wants to spin off its medtech division: common operations are no longer a safe business.
Zimmer Biomet is cutting up to 490 jobs in its production facility in Winterthur. The move comes as the orthopedic industry faces challenges, with Johnson & Johnson (J&J) deciding to spin off its Medtech division. J&J's Medtech business reported a 2.5% growth in revenue to $8.6 billion in the third quarter, but the company missed its growth targets.
The global market for hip and knee implants was valued at around $18 billion last year, with four companies - J&J, Stryker, Zimmer Biomet, and Smith + Nephew - controlling over 70% of the market.
Written by urgent.news from NZZ Wirtschaft's report — not a translation of it. Machine-written — may contain errors; check the original before relying on it.
